Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease

Objectives Dyslipidemia exists within the setting of NAFLD and the relationship of a normal level of low-density lipoprotein cholesterol (LDL-c) with NAFLD is largely unknown. This large population-based study aimed to investigate the association between LDL-c levels within the normal range and the incidence of NAFLD. Methods A total of 60527 subjects from 2 medical centers who had undergone liver ultrasonography were initially enrolled into this study. NAFLD was defined by ultrasonographic detection of steatosis in the absence of other liver disease. Subjects were divided into 4 groups (Q1 to Q4) by normal LDL-c quartiles : Q1: ≤ 2.00, Q2: 2.10-2.35, Q3: 2.36-2.68 and Q4: 2.69-3.12 mmol/L. The odds ratios (OR), hazard ratio (HR) and 95% confidence intervals (CIs) for NAFLD were calculated across each quartile of LDL-c, using the Q1 as reference. Results The prevalence rates of NAFLD in a cross-sectional population from Q1 to Q4 were 19.34%, 25.86%, 35.65% and 42.08%, respectively. The OR for NAFLD in the cross-sectional population were 1.31 (95% CI 1.14-1.54), 1.73 (95% CI 1.46-2.04), and 1.82 (95% CI 1.49-2.23), respectively, after adjusting for known confounding variables. The HR for NAFLD in the longitudinal population were 1.23 (95% CI 1.12-1.35), 1.57 (95% CI 1.44-1.72) and 2.02 (95% CI 1.86-2.21), compared with Q1. Subjects with higher LDL-c level within the normal range had an increased cumulative incidence rate of NAFLD. Conclusions Increased levels of LDL-c within the normal range may play a significant role in the prevalence and incidence of NAFLD, independent of other confounding factors.

• Publication year

  2015

• Venue

  OncoTarget

• Publication date

  2015-12-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.18632/oncotarget.6799PMID 26735337PMCID 4868717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-alcoholic fatty liver disease.

  2016cited by this paper
• Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease

  2016cited by this paper
• Non-alcoholic fatty liver disease in 2015.

  2015cited by this paper
• Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease.

  2015cited by this paper
• Co-existence of insulin resistance and high concentrations of circulating oxidized LDL lipids

  2015cited by this paper
• Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis

  2015cited by this paper
• Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) Is a Novel Nutritional Therapeutic Target for Hyperlipidemia, Non-Alcoholic Fatty Liver Disease, and Atherosclerosis

  2015cited by this paper
• Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease

  2015cited by this paper
• Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study.

  2015cited by this paper
• Nonalcoholic fatty liver disease and cardiovascular disease.

  2014cited by this paper
• The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue.

  2014cited by this paper
• LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicenter Cross-Sectional Study

  2014cited by this paper
• Nonalcoholic fatty liver disease and cardiovascular disease.

  2014cited by this paper
• Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease

  2013influential reference
• Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism.

  2013cited by this paper
• Lipoprotein Metabolism, Dyslipidemia, and Nonalcoholic Fatty Liver Disease

  2013cited by this paper
• Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.

  2013influential reference
• Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

  2013cited by this paper
• Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease

  2012cited by this paper
• Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases PDGF-dependent vascular smooth muscle cell proliferation

  2011cited by this paper
• LRP6 Protein Regulates Low Density Lipoprotein (LDL) Receptor-mediated LDL Uptake*

  2011cited by this paper
• Circulating Oxidized LDL and Inflammation in Extreme Pediatric Obesity

  2011cited by this paper
• Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study

  2010influential reference
• Nonalcoholic Fatty Liver Disease as the Transducer of Hepatic Oversecretion of Very-Low-Density Lipoprotein–Apolipoprotein B-100 in Obesity

  2010cited by this paper
• Mammalian target of the rapamycin pathway is involved in non-alcoholic fatty liver disease.

  2010cited by this paper
• Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

  2010cited by this paper
• NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men

  2008cited by this paper
• Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summary

  2007cited by this paper
• LRP6 Mutation in a Family with Early Coronary Disease and Metabolic Risk Factors

  2007cited by this paper
• Nonalcoholic fatty liver disease

  2005cited by this paper
• Nonalcoholic fatty liver disease

  2005cited by this paper
• Systemic Levels of Lipid Peroxidation and Its Metabolic and Dietary Correlates in Patients with Nonalcoholic Steatohepatitis

  2004cited by this paper
• Hepatic lipase mRNA, protein, and plasma enzyme activity is increased in the insulin-resistant, fructose-fed Syrian golden hamster and is partially normalized by the insulin sensitizer rosiglitazone.

  2004cited by this paper
• Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

  2003cited by this paper
• Non‐alcoholic fatty liver disease

  2002cited by this paper
• Nonalcoholic fatty liver disease.

  2002cited by this paper
• Hepatic uptake of chylomicron remnants.

  1997cited by this paper

• Predicting non-alcoholic fatty liver disease (NAFLD) using machine learning algorithms: Evidence from a large-scale community cohort in Taiwan.

  2026cites this paper
• Regulatory mechanisms of hepatocyte PCSK9 expression: translating mechanistic insights into potential nutraceuticals

  2025cites this paper
• Regulatory Mechanisms of Phenolic Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review

  2025cites this paper
• Chronic toxicity mechanisms of 6PPD and 6PPD-Quinone in zebrafish

  2025cites this paper
• Normal caloric intake with high-fat diet induces metabolic dysfunction-associated steatotic liver disease and dyslipidemia without obesity in rats

  2024cites this paper
• A Study of Non-alcoholic Fatty Liver Disease in Patients With Hypothyroidism: A Cross-Sectional Study in a Tertiary Care Hospital

  2024cites this paper
• Association Between Remnant Cholesterol and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis

  2024cites this paper
• Glucose and lipid-related indicators in relation to elevated alanine aminotransferase in a pediatric population

  2024cites this paper
• Gallic Acid Can Promote Low-Density Lipoprotein Uptake in HepG2 Cells via Increasing Low-Density Lipoprotein Receptor Accumulation

  2024cites this paper
• Association between alanine aminotransferase to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: a retrospective cohort study in lean Chinese individuals

  2024cites this paper
• Nomogram for predicting the risk of nonalcoholic fatty liver disease in older adults in Qingdao, China: A cross-sectional study.

  2024cites this paper
• Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD: Jordan’s Perspective Based on Knowledge and Attitude Determinants

  2024cites this paper
• Correlation study between lipid profile parameters and liver function enzymes in Babylon province

  2024cites this paper
• Effectiveness of Resmetirom in Reducing Cholesterol Levels in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis

  2024cites this paper
• Risk Factors of Non-alcoholic Fatty Liver Disease in the Iranian Adult Population: A Systematic Review and Meta-analysis

  2023cites this paper
• Ficus deltoidea Leaf Alters Oxidative Stress, Protein Homeostasis and Ubiquitin-Proteasome Pathways in Fatty Acid-Induced Cell Line

  2023cites this paper
• Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease

  2023cites this paper
• Caffeine can alleviate non-alcoholic fatty liver disease by augmenting LDLR expression via targeting EGFR.

  2023cites this paper
• Triglyceride affects the association between estimated glomerular filtration rate and the onset of non-alcoholic fatty liver disease: A second analysis of a Chinese cohort study

  2022cites this paper
• Medical checkup data analysis method based on LiNGAM and its application to nonalcoholic fatty liver disease

  2022cites this paper
• Styrylpyrones from Phellinus linteus Mycelia Alleviate Non-Alcoholic Fatty Liver by Modulating Lipid and Glucose Metabolic Homeostasis in High-Fat and High-Fructose Diet-Fed Mice

  2022cites this paper
• Evaluated Glomerular Filtration Rate Is Associated With Non-alcoholic Fatty Liver Disease: A 5-Year Longitudinal Cohort Study in Chinese Non-obese People

  2022cites this paper
• Grape-Seed Procyanidin Extract (GSPE) Seasonal-Dependent Modulation of Glucose and Lipid Metabolism in the Liver of Healthy F344 Rats

  2022cites this paper
• Updates in the Epidemiology of Fatty Liver and its Consequences in Saudi Arabia: A Review

  2022cites this paper
• Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol

  2022cites this paper
• Infections at the nexus of metabolic-associated fatty liver disease

  2021cites this paper
• 2019 global NAFLD prevalence - A systematic review and meta-analysis.

  2021cites this paper
• Polygoni Multiflori Radix Praeparata Ethanol Extract Exerts a Protective Effect Against High-Fat Diet Induced Non-Alcoholic Fatty Liver Disease in Mice by Remodeling Intestinal Microbial Structure and Maintaining Metabolic Homeostasis of Bile Acids

  2021cites this paper
• A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH)

  2021cites this paper
• Non-Alcoholic Fatty Liver Disease: Taif Populations’ Perspective Based on Knowledge and Attitude Determinants

  2021cites this paper
• The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients

  2021cites this paper
• One‐carbon metabolism‐related micronutrients intake and risk for hepatocellular carcinoma: A prospective cohort study

  2020cites this paper
• Development and validation of a noninvasive clinical scoring system to predict significant fibrosis in patients with nonalcoholic fatty liver disease.

  2020cites this paper
• Development and validation of a nomogram for predicting nonalcoholic fatty liver disease in the non-obese Chinese population.

  2020cites this paper
• Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study

  2020influential citation
• A Low Creatinine to Body Weight Ratio Predicts the Incident Nonalcoholic Fatty Liver Disease in Nonelderly Chinese without Obesity and Dyslipidemia: A Retrospective Study

  2020cites this paper
• Low-density lipoprotein cholesterol within the normal range and nonalcoholic fatty liver disease in the non-obese Chinese population: a secondary analysis based on a cross-sectional study

  2020cites this paper
• Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility

  2019cites this paper
• Zebra fish model of obesity: Relevance to metabolic syndrome

  2019influential citation
• Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without Diabetes

  2019cites this paper
• Middle‐ and high‐molecular weight adiponectin levels in relation to nonalcoholic fatty liver disease

  2019cites this paper
• ANXA2, PRKCE, and OXT are critical differentially genes in Nonalcoholic fatty liver disease

  2019cites this paper
• Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl-CoA desaturase-1, lipase activity, leptin and resistin

  2018influential citation
• Assessment of the rs2645424 C/T single nucleotide polymorphisms in the FDFT1 gene, hepatic expression, and serum concentration of the FDFT in patients with nonalcoholic fatty liver disease

  2018cites this paper
• The NAFL Risk Score: A simple scoring model to predict 4-y risk for non-alcoholic fatty liver.

  2017cites this paper
• Non-alcoholic Fatty Liver Disease: A Clinical Update

  2017cites this paper
• Elevation of plateletcrit increasing the risk of non-alcoholic fatty liver disease development in female adults: A large population-based study.

  2017cites this paper
• Serum alkaline phosphatase, a risk factor for non-alcoholic fatty liver, but only for women in their 30s and 40s: evidence from a large cohort study

  2017cites this paper
• Impaired learning and memory in rats induced by a high‐fat diet: Involvement with the imbalance of nesfatin‐1 abundance and copine 6 expression

  2017cites this paper
• Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study

  2016influential citation
• World Journal of Gastroenterology

  year unknowncites this paper